C3124
Milieu de cryoconservation de cellules CryoStor®
CS2
Synonyme(s) :
Cell Cryopreservation Solution, Cryopreservation Media
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
NACRES:
NA.75
UNSPSC Code:
12352207
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
sterility
sterile-filtered
form
liquid
technique(s)
cell culture | mammalian: suitable, cryopreservation: suitable
shipped in
ambient
storage temp.
2-8°C
General description
The CryoStor CS2, CS5, and CS10 family of preservation solutions represents the next generation of cryopreservation media. Designed to prepare and preserve cells in ultra low temperature environments (-80 to -196 °C), CryoStor media provide a safe, protective environment for cells and tissues during thefreezing, storage, and thawing process. Through modulating the cellular biochemical response to the cryopreservation process, these media provide enhanced cell viability and functionality, while eliminating the need to include serum, proteins, or high levels of cytotoxic agents.
CryoStor CS2, CS5, and CS10 are a series of cell specific, optimized preservation media, uniquely formulated to address the molecular biological aspects of cells during the cryopreservation process; thereby, directly reducing the level of Cryopreservation-Induced Delayed-Onset Cell Death and improving post-thaw cell viability and function.
These media are recommended for the preservation of stem cells, hepatocytes, tissue samples, and other extremely sensitive cell types.
CryoStor CS2, CS5, and CS10 are a series of cell specific, optimized preservation media, uniquely formulated to address the molecular biological aspects of cells during the cryopreservation process; thereby, directly reducing the level of Cryopreservation-Induced Delayed-Onset Cell Death and improving post-thaw cell viability and function.
These media are recommended for the preservation of stem cells, hepatocytes, tissue samples, and other extremely sensitive cell types.
Application
CryoStor® cell cryopreservation media has been used in the cryopreservation of Plasmodium vivax and P. falciparum sporozoites.
Les milieux de conservation CryoStor, optimisés et spécifiques pour les cellules, sont formulés exclusivement pour soutenir les aspects de biologie moléculaire des cellules lors du procédé de cryoconservation, ce qui réduit directement le taux de mort cellulaire d′apparition tardive induite par la cryoconservation et améliore la viabilité ainsi que la fonction des cellules après décongélation.
CryoStor CS2 is formulated to contain 2% dimethyl sulfoxide (DMSO). Suggested when reducing DMSO is of primary concern.
Cryostor® Cryopreservation Video Protocol
Cryostor® Cryopreservation Video Protocol
Other Notes
Formulation contains 2% DMSO.
Legal Information
CryoStor is a registered trademark of BioLife Solutions, Inc.
Still not finding the right product?
Explore all of our products under Milieu de cryoconservation de cellules CryoStor®
Classe de stockage
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Protocoles
Cryopreservation affects post-thaw recovery, viability, and functionality. Stress during freezing and suboptimal media lead to cell death.
Contenu apparenté
A simple and efficient method for cryopreservation and recovery of viable Plasmodium vivax and P. falciparum sporozoites
Singh N, et al.
Parasitology International, 65(5), 552-557 (2016)
J Stylianou et al.
Cytotherapy, 8(1), 57-61 (2006-04-22)
Hematopoietic stem cells (HSC) have traditionally been frozen using the cryoprotectant DMSO in dextran-40, saline or albumin. However, the process of freezing and thawing results in loss of HSC numbers and/or function. This study investigated the use of CryoStor for
Dominic M Clarke et al.
Cytotherapy, 11(4), 472-479 (2009-06-06)
Peripheral blood stem cells (PBSC) have become the preferred stem cell source for autologous hematopoietic transplantation. A critical aspect of this treatment modality is cryopreservation of the stem cell products, which permits temporal separation of the PBSC mobilization/collection phase from
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| C3124-100ML | 04061833485323 |